Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate-Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group Study AHOD0031

Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risks

(2012) J. M. Yeh et al.   BLOOD

Association Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy and Survival Among Children With Favorable-Risk Hodgkin Lymphoma

(2012) Monika L. Metzger et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-Term Results of CCG 5942: A Randomized Comparison of Chemotherapy With and Without Radiotherapy for Children With Hodgkin's Lymphoma—A Report From the Children's Oncology Group

(2012) Suzanne L. Wolden et al.   JOURNAL OF CLINICAL ONCOLOGY

Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: A report from the Children's Oncology Group

(2012) Cameron K. Tebbi et al.   PEDIATRIC BLOOD & CANCER

Report of satellite workshop on interim-PET in Hodgkin lymphoma: 8th International Symposium on Hodgkin Lymphoma, Cologne, 23 October 2010

(2011) Andrea Gallamini et al.   LEUKEMIA & LYMPHOMA

BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group

(2010) K. M. Kelly et al.   BLOOD

Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study

(2010) S. M. Castellino et al.   BLOOD

Second Malignant Neoplasms in Survivors of Pediatric Hodgkin's Lymphoma Treated With Low-Dose Radiation and Chemotherapy

(2010) Maureen M. O'Brien et al.   JOURNAL OF CLINICAL ONCOLOGY

Procarbazine-Free OEPA-COPDAC Chemotherapy in Boys and Standard OPPA-COPP in Girls Have Comparable Effectiveness in Pediatric Hodgkin's Lymphoma: The GPOH-HD-2002 Study

(2010) Christine Mauz-Körholz et al.   JOURNAL OF CLINICAL ONCOLOGY

Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies

(2010) Günther Schellong et al.   PEDIATRIC BLOOD & CANCER

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425

(2009) C. L. Schwartz et al.   BLOOD

Late Mortality Among 5-Year Survivors of Childhood Cancer: A Summary From the Childhood Cancer Survivor Study

(2009) Gregory T. Armstrong et al.   JOURNAL OF CLINICAL ONCOLOGY

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

(2008) C. Kobe et al.   BLOOD

Subsequent Malignancies in Children Treated for Hodgkin's Disease: Associations With Gender and Radiation Dose

(2008) Louis S. Constine et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS